A new publication describing a cetrorelix-based ovarian synchronization protocol was released on July 15, 2026. The paper, titled "A new cetrorelix-based estrogen-free ovarian synchronization protocol for fixed-time artificial insemination in beef cattle," appears in the journal Theriogenology.
The publication addresses an estrogen-free protocol using cetrorelix for synchronizing ovarian activity ahead of fixed-time artificial insemination in beef cattle. No findings, outcomes, or efficacy data from the study have been provided beyond the title and publication details.
Cetrorelix is an approved compound. This entry reflects only the existence and bibliographic details of this new publication as listed in the source record. Readers interested in the specific study results, methodology, or data should consult the full paper directly through the journal or the linked source.
For broader background on cetrorelix, including its approved uses and general profile, readers can refer to the compound overview.